"/> Invitrogen™ Peptide synthétique KLHL1 humain | B-LABO France

Invitrogen™ Peptide synthétique KLHL1 humain

Réf. : BL-RE-176778Réf. fabricant : 15206349 50 μg
141,00 € HT

Synthetic Peptide

Gene ID (Entrez)
57626
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
Q9NR64
Nom usuel
Human KLHL1
Marque
Invitrogen

KLHL1 Synthetic Peptide, PEP-0120, from Invitrogen.

The mammalian Kelch-like 1 (KLHL1) was initially discovered as a homolog to the Drosophila Kelch gene that is highly expressed in several brain tissues. The predicted protein domain structure of KLHL1 is characteristic of a number of proteins that bind actin, form dimers, and often act as actin-organizing proteins. Based on the presence of anti-sense RNA that spans the transcription and translation start sites as well as the first splice site of KLHL1 in brain tissue of individuals suffering from the neurodegenerative disorder spinocerebellar ataxia type 8 (SCA8), it has been suggested that KLHL1 is involved this disease and that regulation of KLHL1 protein may be affected by antisense RNA expression.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-176778
Réf. fabricant15206349
Gene ID (Entrez)57626
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionQ9NR64
Nom usuelHuman KLHL1
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)KLHL1
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.